文献速递神经MR

低级别胶质瘤手术切除范围对生存的影响因分子亚型而异

Extent of Surgical Resection in Lower-Grade Gliomas: Differential Impact Based on Molecular Subtype.
PubMed 文献 · AJNR Am J Neuroradiol · 2019-06-27

本研究纳入172例WHO II或III级低级别胶质瘤患者,基于FLAIR或T2加权MRI用半自动分割软件测量手术前后肿瘤体积及切除百分比,并按IDH和1p/19q状态分亚型分析其与总生存的关系。结果显示切除百分比在IDH突变型1p/19q非共缺失星形细胞瘤中与总生存关联最强(HR 4.34),在IDH野生型中无显著关联,提示手术切除范围的生存获益因分子亚型而异。

要点

  • 低级别胶质瘤术后肿瘤体积和切除百分比与总生存相关,但获益因分子亚型不同而异。
  • IDH突变型1p/19q非共缺失星形细胞瘤中,切除百分比与总生存关联最强(HR 4.34)。
  • IDH野生型低级别胶质瘤中,术前术后体积及切除百分比与总生存无显著关联。

核心结论

  • 手术切除范围对低级别胶质瘤患者的生存影响因分子亚型而异;IDH突变型低级别胶质瘤从更大范围切除中获益,其中IDH突变型1p/19q非共缺失星形细胞瘤获益最明显。

研究设计与样本

  • 研究纳入172例WHO II或III级低级别胶质瘤患者,基于FLAIR或T2加权MR序列用半自动分割软件测定手术前后肿瘤体积,按IDH和1p/19q状态分亚型,校正年龄、性别、WHO分级、化疗和放疗后分析体积及切除百分比与总生存的关联。

诊断标准与关键数值

  • 全队列:术后肿瘤体积HR 1.80(95%CI 1.18-2.75,P=.006),切除百分比HR 3.22(95%CI 1.79-5.82,P<.001),均与总生存相关。
  • IDH突变型1p/19q共缺失少突胶质细胞瘤:切除百分比HR 6.69(95%CI 1.57-28.46,P=.01),与总生存相关。
  • IDH突变型1p/19q非共缺失星形细胞瘤:术前体积HR 3.20(95%CI 1.22-8.39,P=.018)、术后体积HR 2.33(95%CI 1.32-4.12,P=.004)、切除百分比HR 4.34(95%CI 1.74-10.81,P=.002),均与总生存相关。
  • IDH野生型低级别胶质瘤:术前术后体积及切除百分比与总生存均无显著关联。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

BACKGROUND AND PURPOSE: Diffuse lower-grade gliomas are classified into prognostically meaningful molecular subtypes. We aimed to determine the impact of surgical resection on overall survival in lower-grade glioma molecular subtypes.

MATERIALS AND METHODS: For 172 patients with lower-grade gliomas (World Health Organization grade II or III), pre- and postsurgical glioma volumes were determined using a semiautomated segmentation software based on FLAIR or T2-weighted MR imaging sequences. The association of pre- and postsurgical glioma volume and the percentage of glioma resection with overall survival was determined for the entire cohort and separately for lower-grade glioma molecular subtypes based on isocitrate dehydrogenase (IDH) and 1p/19q status, after adjustment for age, sex, World Health Organization grade, chemotherapy administration, and radiation therapy administration.

RESULTS: For the entire cohort, postsurgical glioma volume (hazard ratio, 1.80; 95% CI, 1.18-2.75; P = .006) and the percentage of resection (hazard ratio, 3.22; 95% CI, 1.79-5.82; P < .001) were associated with overall survival. For IDH-mutant 1p/19q-codeleted oligodendrogliomas, the percentage of resection (hazard ratio, 6.69; 95% CI, 1.57-28.46; P = .01) was associated with overall survival. For IDH-mutant 1p/19q-noncodeleted astrocytomas, presurgical glioma volume (hazard ratio, 3.20; 95% CI, 1.22-8.39; P = .018), postsurgical glioma volume (hazard ratio, 2.33; 95% CI, 1.32-4.12; P = .004), and percentage of resection (hazard ratio, 4.34; 95% CI, 1.74-10.81; P = .002) were associated with overall survival. For IDH-wild-type lower-grade gliomas, pre-/postsurgical glioma volume and percentage of resection were not associated with overall survival.

CONCLUSIONS: The extent of surgical resection has a differential survival impact in patients with lower-grade gliomas based on their molecular subtype. IDH-mutant lower-grade gliomas benefit from a greater extent of surgical resection, with the strongest impact observed for IDH-mutant 1p/19q-noncodeleted astrocytomas.

来源:AJNR Am J Neuroradiol,查看原文。版权归原作者所有。

引用

  1. Patel SH, Bansal AG, Young EB, et al. Extent of Surgical Resection in Lower-Grade Gliomas: Differential Impact Based on Molecular Subtype. AJNR Am J Neuroradiol. 2019. PMID: 31248860. doi:10.3174/ajnr.A6102

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。